Research Article
Clinical Arterial Peripheral Vascular Pathology Does Not Impact Short- or Long-Term Survival after Transcatheter Aortic Valve Replacement
| | Vascular Pathology (n=147) | Control (n=195) | P-value |
| Approach | | | |
| Transfemoral | 76 (111) | 86 (167) | .025 |
| Transapical | 20 (29) | 11 (21) | .030 |
| Transaortic | 1 (2) | 3 (5) | .703 |
| Trans-subclavian | 3 (4) | 1 (2) | .408 |
| Transcaval | 1 (1) | 0 (0) | .430 |
| Mean LOS after TAVR (days) | 5.3 (9.4) | 3.6 (3.2) | .077 |
| Valve type | | | |
| First generation Sapien | 23 (34) | 30 (58) | .178 |
| Sapien XT | 17 (25) | 13 (26) | .367 |
| Sapien S3 | 32 (47) | 34 (67) | .728 |
| First Generation CoreValve | 24 (35) | 20 (39) | .427 |
| CoreValve Evolute | 4 (6) | 3 (5) | .540 |
|
|
Values are mean (standard deviation) or n (%).
|